Adma Biologics Inc’s recently made public that its Director ELMS STEVE unloaded Company’s shares for reported $2.5 million on Mar 19 ’24. In the deal valued at $6.08 per share,411,829 shares were sold. As a result of this transaction, ELMS STEVE now holds 2,115,671 shares worth roughly $13.52 million.
Then, ELMS STEVE sold 49,887 shares, generating $299,821 in total proceeds. Upon selling the shares at $6.01, the Director now owns 2,527,500 shares.
Before that, ELMS STEVE sold 183,008 shares. Adma Biologics Inc shares valued at $1,099,878 were divested by the Director at a price of $6.01 per share. As a result of the transaction, ELMS STEVE now holds 2,577,387 shares, worth roughly $16.47 million.
A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Raymond James also remained covering ADMA and has increased its forecast on November 11, 2021 with a “Strong buy” recommendation from previously “an Outperform” rating. Cantor Fitzgerald started covering the stock on November 09, 2021. It rated ADMA as “an Overweight”.
Price Performance Review of ADMA
On Friday, Adma Biologics Inc [NASDAQ:ADMA] saw its stock jump 1.75% to $6.39. Over the last five days, the stock has lost -3.18%. Adma Biologics Inc shares have risen nearly 41.37% since the year began. Nevertheless, the stocks have risen 98.45% over the past one year. While a 52-week high of $6.76 was reached on 03/28/24, a 52-week low of $3.06 was recorded on 01/03/24. SMA at 50 days reached $5.74, while 200 days put it at $4.36. A total of 2.39 million shares were traded, compared to the trading of 1.92 million shares in the previous session.
Levels Of Support And Resistance For ADMA Stock
The 24-hour chart illustrates a support level at 6.23, which if violated will result in even more drops to 6.07. On the upside, there is a resistance level at 6.52. A further resistance level may holdings at 6.65. The Relative Strength Index (RSI) on the 14-day chart is 58.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.05%. Stochastics %K at 52.27% indicates the stock is a holding.
How much short interest is there in Adma Biologics Inc?
A steep rise in short interest was recorded in Adma Biologics Inc stocks on Mar 15, 2024, growing by 1.84 million shares to a total of 7.99 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 6.15 million shares. There was a rise of 23.03%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.67% of the overall stock float, the days-to-cover ratio (short ratio) rose to 2.51.
The most recent change occurred on June 04, 2019 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $8 price target.
